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INTRODUCTION  
Lower GI malignancies though more common in the west are on 
the increase in our country for the past decade 44. Few topics in cancer 
research have engendered more excitement than the recent discovery of 
identifiable genetic defect in patients with inherited as well as sporadic 
form of colorectal carcinoma & the ideal goal of treatment in lower GI 
malignancies is the eradication of disease with preservation of anatomic 
& physiological function. 
There are evidences that neoplastic disease has affected humans 
since prehistoric times. Mummies from pre – Columbian, Peru of 2400 
years ago as well as Egyptian mummies from 3000 B.C. have metastatic 
skeletal deposits. It was Hippocratic (460 – 370 B.C.) who first proposed 
a theoretical framework to explain cancer invasion. 
The cellular etiology of cancer was first described by Johannes 
Peter Muller in 1828. The following year Joseph Calrude Recaemer 
proposed that invasion and distant spread were the result of translocation 
of cells and he coined the term metastasis. The first successful resection 
of colonic growth was performed by Reynoard Lyons in 1823. 
After Billroth, Czerny and Mickulicz, the pioneers in abdominal 
surgery familiarized, the technique of intestinal resection and anastamosis 
& increasing number of colonic resections were attempted. The combined 
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operation involving abdominal and perineal phases for excision of the 
rectum was first performed by Czerny (1883). But it was undoubtedly the 
work of Emest Miles (1908) that established the abdomino perineal 
operation. 
Cuthberk Dukes (1935) classified carcinoma of rectum into 3 
stages and explaining macroscopic variations 1. These are widely used  by 
pathologists with minimal changes even now for colorectal cancer staging 
.Paul of Liverpool (1895) and Mikulicz of Brestan (1903) devised extra 
peritoneal resection of carcinoma colon and popularized the technique in 
America. 
Halstead (1895), Shoemaker (1921) Ranken (1928) and 
Wangenstein (1940) described various methods of anastamosis by which 
it was hoped to carry out resection and anastamosis in an entirely sterile 
manner without opening  the bowel lumen till union was completed. But 
it was later pointed out by Moyhnian that the factor responsible for sepsis 
is not contamination during the operation itself but subsequent leakage. 
Whipple (1931) and Turner (1937) favoured intraperitoneal 
resection with temporary caecostomy in order to relive the tension on the 
suture lines. Devine (1931) developed preliminary defunctioning 
colostomy which helped mechanical cleansing of the distal bowel. 
After advent of strong intestinal antiseptics, reliance was placed on 
them entirely and a primary colostomy was entirely omitted. Lloyd Davis 
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Morgan and Yollinger (1953) carried out resection with immediate 
anastamosis without any form of proximal decompression. In their series 
of 109 cases, there were only 3 postoperative deaths and none of them 
was due to sepsis. 
In recent years, the trend is towards preparation with mechanical 
cleansing using balanced salt solutions containing osmotic purgatives in 
them with antibiotics, orally or IV 24. This requires only single day 
preoperative preparation 16. 
Surgical resection remains the mainstay of treatment for Lower GI 
malignancies 2. Radiotherapy and chemotherapy are used as adjuvant 
therapeutic options. Turnball at the Cleveland clinic recommended a no 
touch technique in which vascular and mesenteric division was first 
undertaken, thereby isolating the tumour. 
The role of gene and their abnormality are being studied 
extensively and has given us the adenoma to carcinoma model due to 
accumulation of various genetic defects in the form of deletion, 
translocation etc. These may help us to find appropriate diagnostic tool to 
look for such aberration early, preventing cancer progression.. 
Colorectal surgery has advanced a lot with introduction of endo 
GIA staplers. Especially for sphincter saving procedures for carcinoma   
rectum31 with the advent of the laparoscope , laparoscopy assisted 
resection procedures are also being carried out 13.  
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AIM 
 
 
The aim of the study is, 
 
1. To study the clinical presentation of lower GI malignancies, 
including the incidence of emergencies. 
 
2. To study the macroscopic and histopathological types of lower GI 
malignancies in our institution. 
 
3. To evaluate various types of surgeries for lower GI malignancies 
being performed in our institution. 
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REVIEW OF LITERATURE  
SURGICAL ANATOMY OF LOWER GI TRACT   
 The small intestine is 6 meters in length. This includes the lower 
mobile part beyond the DJ flexure (proximal 2/5 is jejunum & distal 3/5 
is ileum) .The large intestine extends from end of ileum to anus and 
comprises of the caecum (with appendix) colon, rectum, anal canal, 
measuring between 110 – 170 cm in length on an average 135 cm long.  
EMBRYOLOGY: 
The small intestine develops from midgut. The large intestine 
develops from both mid gut and hind gut. Midgut portion extends from 
caecum to the proximal 2/3 of transverse colon supplied by superior 
mesenteric artery. Hindgut, from distal 1/3rd of transverse colon to 
proximal anus is supplied by inferior mesenteric artery. The distal anal 
canal is ectodermal in origin & is supplied by internal pudendal vessels.  
Large guts starts developing by fifth week of gestation and is 
completed by eight week of gestation when the anal membrane ruptures. 
During sixth week, migration and midgut rotation occurs over 4 weeks 
assuming final anatomic position by 10 week of gestation. 
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ANATOMY 
THE JEJUNUM & ILEUM : 
     The Jejunum & Ileum measure nearly 5 to 5.5 meters, of this proximal 
2/5 is jejunum & distal 3/5 is ileum . The jejunum & ileum are supplied 
by the branches of superior mesenteric artery.. Venous drainage is 
through superior mesenteric vein. The lymph vessels accompany the 
veins & end in 3 sets viz.,1.distal set , 2. intermediate set.,3. proximal or 
superior mesenteric nodes. 
THE CAECUM : 
The caecum, lies in the right iliac fossa, approx.7 cms in length and 
width. Proximally becomes ascending colon at it’s junction with terminal 
ileum guided by a valve which prevents reflux . 
It lies on iliac and psoas muscle and on genitofemoral, lateral 
cutaneous nerve of thigh. It’s exact position is variable, may extend into 
true pelvis. It is almost completely enveloped by peritoneum often 
attached to iliac fossa medially and laterally.( Fig.1) 
THE ASCENDING COLON : 
 It varies from 10 -  20 cms. It lies on iliac – muscle, iliac crest, 
quadrates lumborum and crossing lateral cutaneous nerve of thigh, 
ilioinguinal and iliohypogastric nerves, usually covered with peritoneum 
on all 3 sides except posteriorly. Where it is fixed to post abd wall, 
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sometimes it may be fixed by a short mesentery. It ends at hepatic flexure 
where it turns left on the lower portion of right kidney.  
THE HEPATIC FLEXURE : 
 At this point the colon turns sharply medially and slightly forwards 
downwards just below right lobe of liver and overlapped by it, posteriorly 
lies on lower aspect of right kidney. 
THE TRANVERSE COLON : 
 It the longest of all, varying from 40cm to 70cm in length 
extending from hepatic flexure to splenic flexure forming a dependent 
loop between the points. It is suspended by transverse mesocolon which 
is attached to descending part of duodenum, lower aspect of body of 
pancreas and anterior surface of left kidney. It contains middle colic 
vessels and branches of left colic artery, right colic artery and lymphatics.    
THE SPLENIC FLEXURE : 
 It is junction of transverse colon and descending colon in left 
hypochondrium. The turn is so acute, transverse colon overlaps it 
anteriorly. Related to spleen and pancreatic tail superiorly and front of 
left kidney, medially attached to diaphragm level with X, XI, ribs via 
phrenicocolic ligament which lies below the antero lateral pole of spleen. 
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THE DESCENDING COLON : 
 It extends from splenic flexure to rim of true pelvis close to 
inguinal ligament from where it continues as sigmoid measuring 25 cm. 
Attached to posterior abdominal wall by peritoneum, in left  paravertebral 
gutter to left iliac fossa. It rests on the same muscle and related to the 
same nerve as ascending colon.  
At antero superior iliac spine it turns medially, superior to inguinal 
ligament and lies on femoral nerve, psoas muscle, genital vessels, 
becomes sigmoid colon anterior to external iliac vessels.  
THE SIGMOID COLON : 
It is the most variable part measuring 40 – 80 cm in length. 
Extends upto rim of true pelvis where it becomes the rectum, suspended 
by sigmoid mesocolon, a long mesentery with short base.( Fig.4 ) 
The position, shape, vary very much depending on its length, length and 
mobility of its mesocolon, the degree of distension,condition of rectum, 
bladder, uterus. 
THE RECTUM : 
 It lies in the true pelvis measuring about 12 – 15 cm with a 
diameter of 4 cm when empty. It is dilated in the lower part to form rectal 
ampulla. 
It follows curve of sacrum and coccyx, runs anteriorly, inferiorly to 
central perineal tendon lies on levator ani muscles, anococcygeal 
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ligament. It ends posterior to central perineal tendon and to the apex of 
prostate in male by turning posteriorly and inferiorly as anal canal.  
It follows the curve of sacrum & coccyx in sagittal plane. In 
coronal plane it is shaped giving rise to prominent folds in the lumen 
known as Houston’s valves. 
 The relationship of pelvic peritoneum to rectum is of considerable 
surgical importance. The upper third has a complete peritoneal 
investment except for a thin strip posteriorly where peritoneum is 
reflected as the two leaves of thick mesorectum. As rectum descends into 
pelvis, the uncovered portion becomes wider until only anterior aspect 
has a peritoneal coat in middle 1/3 of rectum. This peritoneum gets 
reflected forward in the bottom of rectovesical pouch or rectouterine 
pouch leaving lower third of rectum extra peritoneal.   
    Posteriorly the parietal pelvic fascia is thickened to form fascia 
of Waldeyer’s separating rectum from sacrum coccyx, blood vessels, and 
nerves. Anteriorly separated by the fascial layer known as Denon villier’s 
fascia.  
The upper 2/3 of rectum is separated from pelvic fascia by 
posterior cushion of areolar tissue which becomes circumferential below 
rectovesical / rectouterine pouch carrying blood vessels and its 
lymphatics known as mesorectum.  
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THE ANAL CANAL : 
It is about 4 cms long with anterior wall shorter than posterior one. 
When empty its lumen is a triradite longitudinal slit, posteriorly 
anococcygeal ligament separates it from coccyx while inferiorly perineal 
body separates it from membranous urethra, penile bulb or lower vagina 
laterally, ischiorectal fossa. It’s whole length is surrounded by sphincters 
which keeps it closed. 
The mucosa of anal canal consists of an upper mucosal and lower 
cutaneous part, the junction being marked by line of anal valves about     
2 cm from anal orifice known as Dentate line . 
 
             BLOOD SUPPLY AND LYMPHATIC DRAINAGE : 
 These two are important subjects in relation to malignancy and its 
treatment.  
BLOOD SUPPLY : 
 The main arteries supplying the jejunum, ileum, colon, rectum are 
superior mesenteric artery, inferior mesenteric artery, middle, inferior 
rectal arteries. The jejunum, ileum, caecum, ascending colon, hepatic 
flexure and proximal two thirds of transverse colon derive blood supply 
from superior mesenteric artery originating from aorta at L1 level via ileo 
colic , right colic, middle colic vessels. The distal third of transverse 
colon, splenic flexure, descending colon, sigmoid and upper third of 
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rectum via inferior mesenteric artery rising from aorta at L3 level via left 
colic, sigmoid branches and superior rectal artery. The distal two thirds of 
rectum, anal canal get blood supply via middle, inferior rectal artery of 
internal iliac artery, internal pudendal artery. 
 The jejunal & ileal branches form multiple arterial arcades to 
supply the jejunum & ileum. The main colic arteries proceed to colon and 
bifurcate to from branches which unite to form arcades an inch or so from 
mesenteric border, so that a continuous chain of communicating vessels is 
formed. This is the marginal artery of Rolando , from it, the ultimate 
branches supply the colon. ( Fig.2 ) 
 These branches ramify between and supply muscular layers, divide 
into small submucosal rami and enter the mucosa. The marginal artery is 
responsible for bringing the area of supply of the superior mesenteric 
artery into communication with that of inferior mesenteric by connecting 
the descending branch of the middle colic with the ascending branch of 
the left colic by means of long anastomosis of colon.( Fig. 3 ) 
 The venous drainage follows its arterial blood supply empties into 
portal venous system. The inferior mesenteric vein diverges from artery 
and passes behind pancreas to drain into splenic vein. Splenic vein and 
superior mesenteric vein join behind neck of pancreas to form portal vein 
which drains the blood into liver. 
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LYMPHATIC DRAINAGE 
 The entire jejunum & ileum drain to the 3 sets of nodes situated in 
the distal ., intermediate & proximal positions., The colon and rectum are 
drained by a large number of lymph node numbering 70 – 100 which are 
present as a series draining into a principal nodal group. 
A. INTRAMURAL LYMPHATICS : 
Throughout the jejunum, ileum., colon & rectum, there is a rich 
continuous lymphatic plexus in the submucous or subserous layers of the 
bowel wall  and are inter connected and drain into extramural lymphatics.  
B.EXTRAMURAL LYMPHATICS OF COLON : 
These consist of lymphatic channels and glands which are divided 
into 4 groups. 
1.Epicolic  ,2. Paracolic , 3.Intermediate Colic, 4.Preterminal colic  
 
C.EXTRAMURAL LYMPHATICS OF RECTUM: 
Likewise lymphatics drain to pararectal group in contact with wall 
of rectum, hence to intermediate group around main arterial for (superior 
rectal artery) and hence to nodes near origin of main vessel. 
From upper half of rectum; lymphatic flow to pararectal nodes 
from thence to superior rectal nodes which drain to nodes in lower 
sigmoid colon thence to nodes along inferior mesenteric artery .  
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Laterally along middle hemorrhoidal vessels on either side to 
ischiorectal fossa and thence to internal iliac glands via inferior rectal and 
internal pudendal vessels (above mucocotaneous junction) . 
         Lymphatics of anal canal, below Dentate line descend to anal 
margin, curves laterally to reach medial superficial inguinal nodes. 
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SURGICAL PHYSIOLOGY OF LOWER GI TRACT 
 
The complex process of digestion & eventual absorption of 
nutrients - carbohydrates, proteins & fats, water, electrolytes., & 
vitamins., is the main role of small intestine., Nearly all food is absorbed 
by the small intestine except for indigestible cellulose. 
 The large intestine receives the ileal contents, absorbs water and 
electrolytes and acts as a reservoir for the fecal matter until it is suitable 
to be discharged through the anus. It was calculated by Smidday et al 
(1960) that about 800 – 1000 ml of fluid enters the large intestine each 
day and 150 ml of this is passed in the feces. Complete loss of colonic 
and rectal function occurs during ileostomy and total proctocolectomy 
procedures. The importance of terminal 30 cm of ileum was emphasized 
by Lillcher and Wangensteen (1956) urging conservation if possible. 
When ileocaecal valve is removed in right hemicolectomy bowel 
function is altered to give an increased stool frequency upto 4 times a 
day. This is due to colonic reflux with bacterial colonization of small 
bowel and loss of regulating valve. After left hemicolectomy only a slight 
increase in stool frequency occurs.  
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INCIDENCE / EPIDEMOLOGY 
 
It is a dynamically changing disease entity due to multifactorial 
reasons. It is predominantly a tumour of old age > 50 yrs and can occur in 
young individuals (genetic inheritance) 
90% of carcinoma occurs in people more than 50 yrs old 4. There is 
a definitive male preponderance (more in rectal carcinoma than colonic 
and small bowel tumours) averaging 1.3 – 1.8 : 1 sex ratio 3.  
The incidence of cancer is much higher in western countries 
suggesting environmental and genetic factors. The frequency has been 
increasing in our country over the last few years possibly related to 
changing dietary, social habits 44. 
It is observed from earlier statistics Smiddy, Goligher (1967) that 
recto sigmoid accounts for more than half cases of colorectal cancer. Now 
there is a progressive trend towards disease of right colon and fewer left 
colon and rectal cancers. (Cardy B Person, 1977, Steele GD 1979). In this 
study, there was more cases involving the left side 31.  
Carcinoma of Rectum accounts of nearly one third of all cancers, 
followed by carcinoma of sigmoid colon, cancer caecum and recto 
sigmoid junction – followed by others. In order of decreasing frequency 
in others are transverse colon, ascending colon, descending colon, splenic 
flexure and hepatic flexure (Bailey & Love)  
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ETIOPATHOGENESIS: 
Numerous risk factors and associated conditions viz., FAP, 
HNPCC, Peutz-Jeghers Syndrome, Crohn’s disease, Ulcerative Colitis, 
celiac sprue, smoking, alcoholism, consumption of red meat have been 
found to be associated with increased risk for small bowel tumours. The 
exact cause of colorectal cancer is not known precisely, with recent work 
providing that a complex interaction between genetic makeup and the 
environment in which the subject resides determines the incidence 42. 
Majority of neoplasms are adeno carcinomas, with malignant melanoma, 
squamous cell carcinoma being rare variants in anal canal. 
ETIOLOGY: 
Genetic Predisposition: 
Approximately 10 – 15% of colorectal cancer is familial. 1 in 200 
person may carry those genes, with mutation in these genes responsible 
for 15% of sporadic cancers 43.  
Hereditary non polyposis colon cancer: 
 Warthin in 1913 recognised increased incidence of cancer in 
families with lynch characterizing these cancer – prone families which 
was not associated with multiple polyps, hence the name. 
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Two distinct clinical presentations were made out, 
Lynch Syndrome I  - Site specific proximal colon cancer in the family.  
Lynch Syndrome II - Characterised by the development of colorectal,    
                                  endometrial, gastric, upper urinary tract, ovarian  
                                  and other malignancies.  
Familial adenomatous polyposis: It is an autosomal dominant 
disorder, diagnosed when a patient has more than 100 adenomatous 
polyps in colon or when a member of an FAP family has any number of 
colonic adenomas detected. The basic defect is due to mutation in APC 
gene located in chromosome 5 q21 locus 33. All patients with this defect 
will develop colonic cancer if left untreated, hence recommendation state 
periodic colonoscopic examination and prophylactic polypectomy with 
HPE to rule out carcinoma or prophylactic proctocolectomy. One marker 
is congenital hypertrophy of retinal pigmented epithelium seen in 70 – 
80% by opthalmoscopy. 
Variants of FAP are, 
Attenuated adenomatous polyposis coli. The patients have less 
number of polyps with same high risk of malignancy. 
Hereditary flat adenoma syndrome develops small adenoma, less 
than 100, frequently dysplatic prone for malignant change. 
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Others in spectrum of hereditary polyposis syndrome are 
A. Gardner’s Syndrome  – Colonic polyposis, epidermal inclusion cyst,    
                                             osteomas of bone, upper GI Tumours. 
B. Turcot’s Syndrome    –   Colonic polyps with Brain Tumours  
      (medulloblastoma) 
Environmental Factors: 
Diet:  
Proposed as a significant etiologic factor, fats suggested to be toxic 
to intestinal mucosa with saturated fats to be more carcionogenic. Studies 
have shown that people whose diet contain <5% fat have lower incidence 
of colorectal cancer.  
 Other compounds suggested to be carcinogenic are fecapentanes 
produced by gutflora, 3 ketosteroids metabolic product of cholesterol, 
pyrrolysis product formed by smoking or deep frying meat products, rice, 
etc. Even increased bile acids are thought to be carcinogenic.  
 Deficiency of compounds such as calcium, vitamin D, A, Vitamin 
C, tocopherol, selenium and dietary fibre may be associated with 
increased incidence due to decreased protective effects by them. 
 This dietary role is proved by people who immigrate from low risk 
regions to high risk region acquiring high risk in a generation time. 
 
 
 
19
Carcinogens: 
 No clear relationship has been established between specific 
carcinogens and small bowel, colorectal cancer. Potential agents under 
study include Bile acids, food additives, smoking, alcohol, ionizing 
radiation, oxygen free radicals may serve as promoter or stimulants to 
altered gene development. 
 
PRE MALIGNANT CONDITIONS: 
Ulcerative Colitis: 
 Overall incidence of cancer in patient with pan colitis is 1% per 
year after 10 yrs by 20 yrs, Dysplasia is a precursor to cancer. But 
implication of polyps, adenomas is not fully clear. Once dysplasia is 
identified removing colon is the most effective method to prevent cancer. 
Risk of cancer in dysplasia is upto 30%   
Crohn’s Disease: 
 Overall incidence of cancer is 7% over 20 yrs. Risk of cancer is 
high in bypassed segments, in fibrotic narrowing, and sites of 
stricturoplasty. 
Previous malignant disease: 
 Patient who underwent treatment for cancer large bowel have three 
fold increased risk of second endorectal malignancy.  
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Polyps: 
 Adenomatous polyps more than 2 cm in size are prone for 
malignancy. Patient with multiple polyps, villous adenomas when 
compared to tubular ones have increased incidence 15.  
Influence of hormones: 
 The lining of colon is exposed to a variety of endogenous 
substances exerting tropic effects on mucosa. Gastrin appears to be most 
directly related to colonic carcinogenesis.Leptin acts as a mitogenic and 
antiapoptotic factor for Colonic cancer cells 28  
Elevated levels have been demonstrated in patients with colorectal 
cancer. Other growth factors associated are transforming growth factor 
(TGF), Bombesin, IGF. 
Others: 
Pelvic Radiation : Supportive, but inconclusive evidence found 
between radiation and intestinal tumours. Over all risk is very small. 
Previous Non cancer Surgery: 
 Cholecystectomy, uretero sigmoidostomy patients have increased 
incidence.  
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PATHOLOGY AND SPREAD 
     In initial stages, cancer of lower GI tract takes the form of localised 
area of thickening of the normal mucosa or a hard nodule in a preexisting 
adenoma or villous papilloma. 
 
There are 4 distinct macroscopic types. (Fig. 5) 
A. Polypoid or cauliflower growth (Fungating / Exophytic): 
 This produces a large fungating mass which projects into the lumen 
of the bowel and is not usually associated with much infiltration of the 
intestinal wall more commonly seen in proximal colon, ascending colon, 
caecum, etc. 
B. Annular or constricting or circumferential growth: 
These lesions extend around bowel wall and the bowel looks as if 
deeply constricted by a string around it., more commonly seen in left 
sided growths i.e., descending colon, sigmoid colon. 
C. Ulcerating Growth: 
Presents as a typical malignant ulcer and this infiltrates the bowel 
wall producing deformity and narrowing of the lumen. 
D. Stenosing or Diffusely infiltrating growth: 
This corresponds to linitus plastica of stomach and produces 
thickening of the intestinal wall usually extending for at least 2 – 3 inches 
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and for most part covered with intact mucosa., more common in the left 
side growths. 
While all consider the above types as the 4 macroscopic 
appearances, Duke classified adenocarcinomas which produce abundant 
mucin as.,  
E. Colloid Carcinoma : This forms a bulky growth with getatinous 
appearance and may or may not be associated with ulceration and 
infiltration. 
Histologic Types: 
 The most common type is adenocarcinoma ( Fig. 6 A, 6 B ), the 
other types are: 
 1. Mucinous adenocarcinoma     2. Signet ring cell adenocarcinoma 
 3. Squamous cell Carcinoma      4.Adenosquamous Carcinoma 
  5. Undifferentiated Carcinoma 
Other types are  Carcinoid tumours 
   Non epithelial tumours 
Degree of Differentiation: 
 In general papilliferous growths tend to be better differentiated 
than the ulcerating or infiltrating type.  
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Broders grading: 
Broders designated adenocarcinoma into 4 grades based on 
percentage of differentiated tumour cells. 
Grade I    :  Well differentiated tumours, closely resembling an adenoma 
Grade II  :  Tumour cells more crowded together but still arranged in           
                      fairly regular pattern.  
Grade III :  Less differentiated and arranged in irregularly folded rings. 
Grade IV : Anaplastic cells which did not form glandular structures at  
                      all. 
Mucoid tumours vary considerably and were graded separately by 
Duke. 
Duke’s Grading: 
 Duke considered arrangement of cell and evolved into new three 
grade system. 
Grade I :  Well differentiated , well formed tubules with least  
nuclear pleomorphism and mitosis. 
Grade II  : Moderately differentiated. 
Grade III  : Least differentiated – occasional glandular structure.,  
more pleomorphic cells, large number of mitosis. 
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SPREAD OF LOWER GI MALIGNANCIES 
Most of our knowledge of spread was due to studies by Dukes 
(1930) Gordon – Watson. 
A. LOCAL INVASION: 
 First spread after initial mucosal growth was to protrude into the 
lumen. Lateral invasion was more in transverse direction leading to 
circumferential growth. (Duke, Black and Waugh)., Mural penetration 
leads to local failure and peritoneal seeding. Additional spread is via 
perineural spaces with invasion reaching as far as 10 cm from the primary 
tumour 32. 
B. LYMPHATIC EXTENSION: 
 Lymph nodal metastasis occurred only after tumours have 
penetrated into first set of nodes. Lymphatics spread occur in an orderly 
fashion via the three echelons of nodal systems. 
Retrograde spread occurs on blockage of central nodes. The risk of 
lymphatic spread increases with increasing tumour grade. As spread 
follows the course of blood vessels supplying the carcinomatous region, 
appropriate fields of excision is worked out by reference to arterial 
supply.  
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C. HEMATOGENOUS SPREAD: 
 The liver is the primary site of hematogenous spread., followed by 
lungs. As venous drainage of rectum is via dual systems, liver and lung 
are involved primarily depending on site of tumor origin in rectum. 
 Batsons vertebral plexuses represent another way of blood spread 
of metastasis to bone and CNS. 
D. IMPLANTATION: 
 It refers to release of tumour cells from primary site and their 
deposition on another surface, it can occur transluminally, 
transperitoneally after seroal invasion and during surgical manipulation 
diminishing curative resection and increasing local failure rate, and 
distant deposits.  
 
STAGING AND CLASSIFICATION 
Duke presented the first original staging for rectal carcinoma which 
is widely used now to stage both colorectal tumours. 
DUKE STAGING (1930): 
 A - Growth limited to colonic / rectal wall but not through 
 B - Growth penetrating through Bowel Wall 
 C - Involvement of lymph node regardless of extent of  
Bowel wall penetration 
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1935 Modification: 
 A, B as same. 
- C1  - Locally positive nodes 
C 
- C2  - Positive nodes at point of ligature 
ASTLER AND COLLINS MODIFICATION: 
 A - Limited to Mucosa 
 B1 - Extending into, but not through propria with  
uninvolved nodes. 
 B2 - Extending into and through mucularis propria,  
   with uninvolved nodes 
 C1 - Extending into, but not through muscularis propria  
   with involved nodes 
 C2 - Extending through M.Propria with involved nodes. 
This staging allowed separation of wall penetration and nodal status. 
TNM CLASSIFICATION FOR COLONIC CANCERS: 
T  - Tumour Stage 
T1 - Into submucosa  
T2 - Into muscularis propria 
T3 - Into pericolic fat but not breaching serosa 
T4 - Breaches serosa or directly involving another organ 
N - Nodal stage 
N0 - No Nodes involved 
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N1 - 1 or 2 nodes involved 
N2 - 3 or more nodes involved 
M - Metastasis 
M0 - No metastasis 
M1 - Metastasis 
Ly - Lymphatic invasion 
L0 - No lymphatics involved 
L1 - Lymphatics involved 
V - Venous invasion 
V0 - No vessel invaded 
V1 - Vessels invaded 
R - Residual tumour 
R0 - No residual tumour 
R1 - Margins involved, residual tumour present 
TNM staging for Rectal cancer 
 T1 - Tumour invasion through muscularis mucosa but not  
into muscularis propria 
 T2 - Tumour invasion into but not through muscularis  
Propria 
 T3 - Tumour invasion through muscularis propria but not  
through serosa 
 T4 - Tumour invasion through serosa or mesorectal fascia 
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 N0 - No nodes involved 
 N1 - 1 – 3 nodes involved 
 N2 - 4 or more nodes involved 
 M0 - No metastasis  
 M1 - Distant metastasis 
 
TNM staging for anal malignancies 
Primary Tumour (T) 
 Tx - Primary tumour cannot be assessed 
 T0 - No evidence of primary tumour 
 Tis - Carcinoma in situ 
 T1 - Tumour < 2.0 cm in greatest dimension  
T2 - Tumour >2.0 cm but not > 5.0 cm  
 T3 - Tumour > 5.0 cm 
T4 - Tumour of any size that invades adjacent organ(s) 
 
Regional Lymph Nodes 
 Nx - Regional lymph nodes cannot be assessed 
 N0 - No regional lymph node metastasis 
 N1 - Metastasis in perirectal lymph nodes 
 N2 - Metastasis in unilateral internal iliac and / or inguinal  
lymph nodes 
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 N3 - Metastasis in perirectal and inguinal lymph nodes and   
or bilateral internal iliac and / or inguinal lymph nodes 
Distant Metastasis (M) 
 Mx - Distant metastasis cannot be assessed 
 M0 - No distant metastasis 
 M1 - Distant metastasis. 
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CLINICAL FEATURES 
There are 3 main ways in which carcinoma of lower GI malignancies may 
present. 
A. As non emergency cases with insidiously developing chronic 
symptoms chiefly affecting bowel function and general health. 
B. As emergencies with perforation / obstruction of bowel with or 
without peritonitis. 
C. Non specific symptoms 
The common symptoms comprise the following 44: 
 Altered bowel habits in the form of alternating constipation and 
diarrhea, tenesmus etc., 
 Pain  
 Sense of incomplete evacuation 
 Bleeding per rectum 
 Mucus per rectum 
 Mass per abdomen 
 History of haemorrhoids 
 Unexplained anaemia 
 Abdominal pain / dyspepsia 
 Loss of weight, asthenia, impairment of general health 
 Loss of appetite 
 Flatulent distension 
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 Acute on chronic bowel obstruction 
 Bowel perforation / peritonitis 
 
Fairly definite correlation between site, type of growth and 
symptomatology occurs. Carcinoma of left colon and rectosigmoid 
present early due to stenosis / circular growth whereas right colon growth 
present late. Local spread may present with related symptoms like 
rectovaginal fistula, recto vesical fistula, urinary obstruction, hemorrhoids 
etc., 
Carcinoma of the small bowel: 
This includes adenocarcinomas, carcinoid tumours, malignant 
GISTs, and lymphomas which present with mainly pain, weight loss, 
anemia, diarrhea, tenesmus, passage of large amount of mucus, lower GI 
bleed, malena and acutely as obstruction or perforation.  
 
Carcinoma of caecum and ascending colon: 
 Most present with anemia, severe and unyielding to treatment. A 
palpable tumour may be present. Sometimes discovered unexpectedly at 
operation for acute appendicitis for an appendicular abscess failing to 
resolve. Sometimes carcinoma of caecum can be the apex of an 
intussusception presenting with intermittent obstruction 49. 
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Carcinoma of transverse colon: 
 It may be mistaken for carcinoma of stomach due to position of 
tumour together with anemia and lassitude. 
Carcinoma of left side of colon: 
 Majority of tumours occur in this location. They are usually of 
stenosing, annular, ulcerative type. The main symptoms are those of 
increasing intestinal obstruction. Colicky or constant aching pain may be 
the only symptom. Alteration in bowel habits, palpable lump, abdominal 
distension are the other symptoms. 
Carcinoma of rectosigmoid: 
 Colicky pain, tenesmus, are the usual symptoms., Rectal carcinoma 
presents usually with bleeding per rectum, sense of incomplete defecation 
tenesmus and alteration in bowel habits. Subacute intestinal obstruction 
may induce colicky pain abdomen. Pain in the back, sciatica indicate 
local sacral plexus involvement. History of piles may be the presenting 
complaint. Symptoms pertaining to local or distant spread may be the 
initial presentation in some. May present as fistula in ano single or 
multiple, discharging pus.  
Carcinoma of Anal Canal: 
 Commonly presenting early with bleeding P/R, pain perianal 
region, mass perianal region. Patient may present with constipation, may 
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also present as fistula in ano., may be mistaken and left behind giving rise 
to obstruction, intestinal distension. 
 
Lower GI Malignancies presenting with acute obstruction: 
 In about 1/5 of patients, complete obstruction occurs either an 
aggravation of chronic affairs or as an acute on chronic obstruction or 
may present one day suddenly as pain, abdominal distension, the 
narrowed lumen plugged by a fecolith, hard stools, undigestable fibres or 
tumours. 
 Chronic obstruction is more commonly encountered with left 
colonic carcinoma rather than right sided lesions. Constricting stenosing 
types seen more on left side and the faecal nature produce greater 
occurrence of acute obstruction.  
Symptoms: 
 Complete obstruction of lower GI tract is often entirely insidious in 
onset. If acute on chronic variety with development of acute obstruction, 
the patient finds he is constipated without passing motion for 2 – 3 days 
despite use of laxatives. He is not able to get rid of flatus and with 
progressively increasing abdominal distention. This state may be 
prolonged with slow increase in abdominal discomfort and distension 
over a period of 6 – 7 days before finally presenting to the hospital. 
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Carcinoma colon with Bowel Perforation: 
 Colonic perforation occurs in 3 – 8% of patients with colo rectal 
cancer. It is often the result of obstructive symptoms prolonged, followed 
by perforation. The common belief was that perforation takes place in a 
stercoral ulcer usually in the caecum and less commonly closer to growth. 
But in a series of 115 cases of carcinoma of large intestine presenting 
with perforation only 20 cases of this type were found, while majority 
was proximal to an obstructing cancer producing localized abscess or 
generalized peritonitis. 
Obstructed cases with perforation of stercoral ulcer: 
 These patients are usually desperately ill with abdominal 
distension, diffuse tenderness, vomiting, gross dehydration and 
electrolyte imbalance. The underlying carcinoma may / may not be 
palpated or suspected from clinical observation. In majority of cases, 
unless supportive measures are done to rapidly stabilize the patient, 
patient condition rapidly deteriorates to end fatally 50.  
Unobstructed cases with perforation: 
 Most of these patients are also gravely ill and shows signs of 
general peritonitis, but owing to the absence of previous obstruction, 
contamination is less. In some, perforation results in localized peritonitis, 
abscess formation, producing diagnostic confusion.  
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 If a sigmoid colon growth perforates, this easily mimics a 
diverticulitis with localized peritonitis with abscess formation. Case 
recordings are present of a left colonic carcinoma perforation and 
subsequent development of subcutaneous abscess of abdominal wall 
(Smith 1963) and subcutaneous emphysema with caecal carcinoma, the 
presentation may mimic an appendicitis or abscess formation.  
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INVESTIGATIONS 
Routine laboratory investigations to be done including complete 
hemogram, B. Urea, B. Sugar, Sr.Creatinine, Urine routine examination, 
E.C.G., Chest X ray, X - ray Abdomen, including Liver Function Tests to 
ascertain general condition of the patient and treatment of these 
abnormalities to allow treatment of cancer. 
Definitive test for detection / diagnosis of lower GI malignancy 
Test for occult blood: 
   Guaiac test – detects 20 mg hemoglobin per gram or 20 ml blood / day. 
High false positive results occur due to presence of other oxidizing 
agents. 
Immuno fluorescent test – detects conversion of hemoglobin to 
fluorescent porhyrins, detects 5 – 10 mg hemoglobin / gm of stool. False 
positives - prohibitively high. 
Rectal examination : reaches approximately 8 cms. 20% colorectal 
cancers palpated and their degree of fixation evaluated.( Fig. 7 )  
Proctosigmoidoscopy: 
Rigid one is 2 cm in diameter 25 cm long, reaching 20 – 25 cm 
from dentate line, detect 20 – 25% of tumours, used for screening low 
risk adults less than 40 yrs with enema to prepare the patient before 
examination. ( Fig. 8 ) 
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Flexible sigmoidoscopy: 
It measures 60 cm in length reaching upto splenic flexure and 
identify 50% of tumours can be done after 2 – 3 prep enemas, used only 
as a diagnostic tool with biopsy taking, with no therapeutic manouvers 
recommended for people over 50 yrs. 
Colonoscopy: 
 Allows visualization of mucosa of entire colon, rectum and usually 
terminal ileum.( Fig.12 ). Measuring about 160 cm in length, it allows 
biopsy, polypectomy, heamorrhage control & stricture dilatation. Major 
complication rate < 0.2% with (Bleeding, anesthetic complications, 
perforations).21 ( Fig. 9 ) 
 Recommended annually or once in 2 yrs in patients with high risk 
of colorectal malignancy with detection of upto 100% of all tumours by a 
experienced one.( Fig.33,34,35 ) 
Contrast Studies: 
 Apart from plain Barium meal series and barium enema, an air 
contrast barium enema is 90% sensitive in detecting polyps >1cm. Risk of 
perforation < 0.02% with barium enema. Water soluble contrast can be 
substituted for barium in patients suspected of perforation.( Fig.10,11 )  
Double contrast barium enema in conjunction with flexible 
sigmoidoscopy will be a cost effective alternative in patients who do not 
tolerate colonoscopy.  
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Imaging techniques: 
These are important in the evaluation, staging and follow up of 
colorectal cancer patients. 
USG Abdomen: 
 Detects early mass lesions involving the lower GI tract & hepatic 
metastasis 30 . 
CT Scan: 
 It allows preoperative evaluation of abdominal cavity to identify 
metastasis, integrity of urinary tract and staging the primary tumour 
lesion especially rectal cancer 48. Angio CT is 95% sensitive to detect 
metastases especially liver. Also 60 – 80% rectal wall invasion and 75% 
of lymphadenopathy can be made out by CT Scan 32. CT colonography is 
replacing barium enema for incomplete colonoscopy. Double Contrast 
CT with CECT with increased cutting slices have improved the efficacy 
of diagnostic methods.( Fig 13,14 ). 
MRI Scan: 
  Phased array pelvic coils are used to detect / stage rectal cancer. 
MRI is more specific for differentiation of cancer from normal tissue and 
fibrotic scar. It is also more specific to make out liver metastases 
especially resectable ones.  
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Positron – Emission Tomography: 
 It is still investigational, and may be most helpful in evaluating 
recurrent tumour in pelvis when dense scar tissue is present, other major 
advantage is to identify extra hepatic / Intraperitoneal disease before 
surgery.  
Trans rectal Ultrasound: 
 Also known as endosonography of rectum used to stage rectal 
cancer., USG image allows clear delineation of rectal wall layers, depth 
of invasion, adjacent origan involvement. 
Positive predictive value  T  < 1 cm - < 50%  
          > 1 cm  – 70%  
Endoluminal USG:  
 Colonoscopic USG in available, allowing determination of depth of 
invasion, attachment to adjacent structures, mesenteric lymph nodal 
spread. Also used for USG guided LN Biopsy.  
Tumour Markers:  
CEA Assay:  
In 1965 Gold and Freedman, isolated a specific antigen in 
adenocarcinoma of the endodermally derived epithelium of the GIT. They 
were also able to demonstrate the same antigen in embryonic and fetal 
digestive tract tissue up to the end of the first 6 months of pregnancy 
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Circulating antibodies to it were found in the sera of a high proportion of 
women throughout pregnancy normal range, varies from 0 – 2.5 ng/ml 22 .  
 Thomas et al (1960) developed RIA capable of detecting minute 
quantities of CEA in serum. Moore et al (1971) further investigated CEA 
and noted that apart from colorectal carcinoma it was found in carcinoma 
pancreas and other GIT cancers, bronchogenic carcinoma, alcoholic liver 
disease and uremia.  
 The main use of CEA assay will be the monitor patients who had 
radical surgery for detecting recurrence of disease, persistence of the 
lesion in metastatic form; other tumour makers include CA 19-9   and 
CA-50.  
 
AFP: 
 Alfa feto protein levels indicate basically liver pathology. Levels 
have been found to be increased in metastatic diseases.   
Immunoscintigraphy 
 A recent development in diagnostic tools utilizes the radiolabelled 
antibody to target tumours for imaging or detection. It is aimed at more 
specific and sensitive tumour imaging. A glycoprotein TAG 72 has been 
found to be useful target antigen in colorectal cancer, the expression of 
which has been found to be high as 94% in colonic adenocarcinoma.  
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 A study using indium III labeled TAG 72 for imaging colon cancer 
showed sensitivity of 70%. Specificity -90% and accuracy 72%. 
Radioimmuno guided   surgery (RIGS) utilizes Radiolabelled antibody to 
localize tumour. Detection achieved by a hand held gamma camera 
detecting problems  during surgery.  
BIOPSY: 
 HPE of the specimen obtained preoperatively either by open or via 
colonoscopy or Proctosigmoidoscopy or laparoscopy is done to study the 
type, grade of tumour and other characteristics 29  
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DIAGNOSIS AND DIFFERENTIAL DIAGNOSIS 
 
Running cancer detection clinics where patients over 45 years are 
investigated thoroughly for visceral malignancies, every year is out of 
question for our rural and urban population. Public education regarding 
early signs of lower GI Malignancies are also not met with much success.  
Most of the cases of carcinoma rectum can be detected by a proper 
rectal examination and this should be mandatory for any patient 
presenting with suggestive symptoms or a history of piles. Colonic 
cancers need further investigations described earlier. Faecal occult blood 
should be done for every patient at high risk. Patients at high risk should 
be screened by luminal contrast studies.  
The investigations available in this hospital apart from routine 
basic investigations are luminal contrast studies, colonoscopy, USG 
abdomen and CT scan. In patients, who presented as acute emergencies, 
diagnosis was confirmed by exploratory laparotomy.  
DIFFERENTIAL DIAGNOSIS:  
 Conditions simulating colonic and rectal carcinoma include 
ileocaecal tuberculosis, appendicular mass, diverticulitis, polyps, Crohn’s 
Disease, Ulcerative colitis  etc. Rectal carcinoma should be differentiated 
from squamous cell carcinoma of anal canal as the treatment is entirely 
different for this. 
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TREATMENT 
The various modalities of treatment for Lower GI Malignancies 
are:  
1. Surgery  
2. Radiotherapy 
3. Chemotherapy   
 
SURGERY:  
 Surgical resection remains the mainstay of treatment and core of 
Lower GI Malignancies. Due to biological unfavourable response to 
chemotherapeutic drugs and radiotherapy due to various reasons, surgery 
is still the best palliative treatment modality 4.  
 The objective of surgery in treatment of lower GI malignancies is 
to remove cancerous segment of bowel, the mesentery containing its 
lymphatics, lymph nodes and any organ directly invaded by the tumour. 
The way surgical resection is done consists of major steps to give 
therapeutic curative resection with as little morbidity and mortality to the 
patient and starts preoperatively itself.  
Preoperative bowel preparations:  
 In this study, a single preoperative Peglec preparation was given 
the day before surgery starting around 11.00 am and ending around 5.00 
pm encouraging the patient to take clear fluids till 10.00 pm. Supportive 
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IV fluids were used then and there. Complete luminal obstruction was an 
absolute contraindication for Peglec preparation. No luminal antibiotics 
were used. Only preoperative antibiotics were used at the induction time.  
Surgical Technique:  
Techniques to minimize tumour spillage, remove adequate bowel 
length and bowel continuity restorations are as important as surgery itself.  
The Abdomen was opened & tumour was assessed for resectability by :  
     Palpating liver for secondaries by visual, palpatory and intraoperative 
USG if available. (Isolated / 3 metastases within one resectable lobe is 
not a contraindication for curative surgery).  
¾ Palpate peritoneum, draining lymph nodes and mobility and fixity 
of tumour to adjacent organs or abdominal wall structures. 
 
Anatomical resection of lower GI malignancies at different sites  
Tumour Location  Vascular Ligation Bowel Resection  
Jejunum and ileum  Jejunal & Ileal Branches With adequate 
margins 
Caecum, ascending colon Ileocolic, Right Colic  Right hemicolectomy
Hepatic flexure , 
Proximal transverse 
colon 
Ileocolic, Right Colic, 
Middle Colic  
Extended right 
hemicolectomy with 
omentectomy   
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Distal transverse colon 
splenic flexure 
 right colic, middle colic, 
left colic 
Extended right 
hemicolectomy with 
omentectomy or left 
hemicolectomy 
Descending colon Inferior mesenteric or left 
colic 
Left hemicolectomy 
Sigmoid colon Inf. Mesenteric or sigmoid Left hemicolectomy 
or sigmoid resection 
Rectum Inf. Mesenteric  or Rectal A.P  Resection / 
anterior resection 
 
Then intestine to be resected is tied both proximally and distally to 
prevent intraluminal spread 6. The major segmental artery supplying the 
cancerous bowel is ligated, and divided. Any adhesion to adjacent 
structures are resected in toto if feasible to avoid loss of curative resection 
(most adhesion, lymphadenopathy may be inflammatory and can only be 
proved histologically). 
The extent of resection depends upon primary location of the 
tumour, lymphatic metastases, adjacent organ invasion. To get a tumour 
free margin, usually 2.5 cm margin clearance is ideal, and anastomosis 
may be end to end or end to side which should be tension free. 
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TREATMENT OPTIONS DEPENDING ON TUMOUR LOCATION 
Jejunal / ileal tumours: 
 Treated by curative resection with adequate margins. ( Fig.15 ) 
Carcinoma Caecum or Ascending Colon :  
Treated by a Right Hemicolectomy . ( Fig.16 ) 
Carcinoma Hepatic Flexure:  
Treated usually by Right hemicolectomy or extended right 
hemicolectomy. ( Fig. 17, 18 ). 
Carcinoma Transverse Colon :  
Depending on position of tumour on Transverse colon. Segmental 
excision of transverse colon. Extended right hemicolectomy may be 
performed. 
Carcinoma Splenic Flexure:  
Treated by resection of colon including transverse, descending if 
needed sigmoid colon with associated lymphatics and mesentery., Left 
Hemicolectomy. ( Fig. 19,20 ). 
 Summarizing the various treatment modalities for rectal 
carcinoma is as follows 46: 
(Extra peritoneal rectum extending upto 11 cm from anal verge) 
 Abdomino perineal resection ( Fig.21,22 )  
 Low anterior resection: 
• End to end / side to end 
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• Sutures / Staples 
 Abdomino sacral resection 
 Coloanal resection 
• Endoanal / Pull through  
• Staples / Sutures  
• End / J.Pouch 
 Localised procedures 
• Local excision 
• Fulguration 
• Endocavity irradiation or brachy therapy 
Tumour free margins are usually achievable for colon cancer and 
usually a margin of 5 cm is deemed adequate, since <2.5% of tumour 
have intramucosal spread more than 2 cms36. During low anterior 
resection, distal margin of 2 cm is deemed adequate for well 
differentiated, small non bulky tumour with favourable prognostic 
features thereby aiding restoration of intestinal continuity 8. 
When synchronous colonic cancers are found at different sites in 
the colon, the preferred procedure is subtotal colectomy. Resection of 
contiguous organs for locally invasive tumours in approximately 10% of 
cases37. Most commonly involved organs are bladder, ovary, ureter, 
abdominal wall, less frequently small intestine, spleen, pancreas, stomach 
and uterus 39. 
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SURGICAL INTERVENTION IN EMERGENCY PRESENTATION: 
The major emergency presentation is obstruction, and perforation 
with later occurring 3 – 8% of all cases and occurring combination in 
about 2% of cancer cases 5. 
Obstruction: 
Immediate surgical treatment is necessary. The surgery is planned 
and carried out. Obstructing cancer either in small bowel or right / 
transverse colon is treated by Resection and primary anastamosis with 
adequate margins, while left sided cancer obstruction is more a difficult 
problem 50. Appropriate surgical procedure depends on location,  
findings, surgeons’ experience and judgement. It can be treated in stages 
with defunctioning colostomy and later curative surgical resection with 
anastamosis. 
Various modalities available: 
 Primary resection with exterioration of both ends. 
 Hartmann’s procedure 
 Primary resection with anastamosis 
 Primary resection with anastamosis protected by proximal 
colostomy or ileostomy. 
 Subtotal colectomy with ileosigmoidostomy 
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PERFORATION 
It is usually a life threatening emergency. Thorough exploration of 
peritoneal cavity is mandatory. Sometimes it may be difficult to 
distinguish mass caused by diverticulosis, perforation from a perforated 
colonic cancer40. 
Goal of surgery 45: 
To remove diseased, perforated segment as dehiscence rate is very 
high in a contaminated field. To do anastamosis protected by proximal 
colostomy / ileostomy. The diverting stoma closure is done 10 weeks 
later, the peritoneal contamination thoroughly irrigated and sucked out. 
The survival rate reaches upto 30% of curative resection at 5 yrs in these 
patients 41. 
LAPAROSCOPIC SURGICAL INTERVENTION: 
 Usually laparoscopic assisted methods are used. Fully laparoscopic 
methods are also attempted. They are claimed to facilitate patient 
convalescence, reduce stress with better post op outcome 17,18.  
Adjuvant Treatment for lower GI Malignancies:  
Chemo radiation forms the main stay of treatment for anal canal  
Tumours 47.  
Radiotherapy: 
 The role of RT is well defined in rectal carcinoma than colonic and 
small bowel tumours35. This is due to variation in local presentation after 
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surgery. In colonic carcinoma the failure site is abdominal rather than 
local site which makes radiotherapy less feasible 26. In rectal cancer local 
failure with recurrence is the most common presentation making adjuvant 
radiotherapy worth while34. In rectal carcinoma, local recurrence in pelvis 
is due to inability to do wide resection due to narrow confines of pelvis 
which is now overcome by laparoscopic methods. Radiotherapy can be 
used in various regimens to prevent local failure 23. 
 Can be used preoperatively 
 Sandwich technique 
 Post operative irradiation. 
Usually 4500- 5000 cGy is delivered over 5 – 7 week period and 
little complications results during preoperative use and complications are 
more after post operative irradiation. 
Unresectable tumours, patients refusing surgery may be treated 
with palliative radiotherapy. Also can be used for palliation of painful 
recurrences and bony metastases. Radiotherapy can be applied using 
Brachy therapy and Teletherapy.( Fig.25,26 ). Most commonly used 
teletherapy are Cobalt therapy and Neutron beam irradiation. ( Fig.27 ) 
Radioactive isotopes are used in brachy therapy with short half life. 
CHEMOTHERAPY: 
 Adeno carcinomas of lower GI tract have usually been resistant to 
chemotherapeutic agents. But CT is appealing and most effective when 
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tumour burden is minimal / smallest and when the fraction of malignant 
cells in growth phase is highest. It is most commonly given following 
surgical procedures. 
 Hence maximum response is obtained for postoperative regimen 
usually for stage III disease with no significant improvement in patient 
with stage II disease. Most experimented drugs are 5 FU alone or 5 FU 
and Cyclophosphamide.,or 5-FU with Levamisole combination with 
leucoverin 51 . Other Drugs include vincristin , irinotecan, oxaliplatin 14., 
 Currently systematic CT is used to improve long term survival by 
reducing incidence of distant metastases, to improve local disease control, 
by combination with external beam radiation, found to have modest 
survival benefits in stage II & III patients. The most promising drug, 
5FU, which acts as radio sensitizer in the chemoradiation techniques 19.  
Immunotherapy: 
 Various agents have been tried to modulate or stimulate innate 
immune response or enhancement of immune response to destroy, 
prevent tumour progression, implantation or metastasis. No encouraging 
results are reported after randomized trials. Commonly used agents are 
levamisole, BCG vaccination , autologous vaccine (irradiated autologous 
tumour cells with BCG) 
 Another strategy is passive – specific immunotherapy using 
monoclonal antibodies especially against CEA antigen and various other 
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tumour antigens, which is said to result in improved disease free, and 
overall survival. Of recent interest is MCA 17 – 1A, which resulted in 
some improvement in Duke Stage C patients. Also MCA – attached with 
tumoricidal drugs used to target metastases, local recurrences etc., all are 
still in experimental stages. 
Treatment of metastatic disease: 
Hepatic metastasis:   
It is important to biopsy liver metastasis for histological diagnosis. 
Patients with upto 2 or 3 liver mets confined to one lobe of the liver may 
be offered liver resection.Multiple painful hepatic metastasis can be 
palliated by cytotoxic drugs, cryotherapy and laser therapy. 
Follow up of lower GI malignancies: 
 The objective of follow up is for early detection of recurrence or a 
metachronous carcinoma that can be treated surgically. The follow up 
program in general consists of periodic history and physical examination, 
fecal occult blood (FOB), CBC, liver function tests, tumour markers, 
colonoscopy and radiographic studies. Colonoscopy is an important 
component of the program. It is a safeguard for detecting anastamotic 
recurrence, missed synchronous lesions and metachronous tumours at 
early stages38. In this study a standard questionnaire was used for all 
patients in the follow up period also. 
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MATERIALS AND METHODS 
 
 This study consists of patients admitted for the management of 
lower GI malignancies in Surgical Wards of Coimbatore Medical 
College Hospital, Coimbatore. Period of Study – 2006 to 2008 
 On admission all the patients were subjected to basic blood 
investigations, Test for fecal occult blood, USG Abdomen, Barium 
studies, CT abdomen and UGI scopy. 
 Following clinical and proctoscopic examination, Colonoscopy 
was done for all patients – except for emergency cases and biopsies 
were taken. 
 Bowel preparation was done preoperatively using plain oral fluids, 
and PEG preparation – the day before surgery. 
 Per operative findings regarding peritoneal implants, liver 
secondaries, peritoneal implants and tumour invasion to the nearby 
structures were noted. 
 Post operative course was closely observed until the first follow up 
visit. 
 Patients with permanent colostomy were followed up for 
colostomy care. 
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OBSERVATIONS AND DISCUSSION 
 
In this series of 78 cases of lower GI malignancies the following 
observations were made. 
Risk Factors: 
Diet: 
Only 4 of the 78 patients were pure vegetarians. The majority of 
patients were illiterate, they could not specify the exact dietary 
constituents. But most patients gave history of consumption of fat and 
spicy food, fibre intake was moderately adequate in most patients. 
Tobacco: 
56 patients out of 78 were using tobacco in some form or other. All 
the male patients except 5 were regular smokers of beedi or cigarettes. 26 
out of 33 female patients were using tobacco in the form of tobacco, pan 
masala etc 41. 
Incidence: 
Age : 
Most of the cases were from older age group. Maximum incidence 
was in the sixth decade i.e. 29 cases in the age group 51 – 60 yrs  14.   
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SEX INCIDENCE 
 
Male Female 
45 33 
 
 
M : F = 45:33 = 1.36:1 
 
SEX INCIDENCE 
58%
42%
Male Female
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 Sex: 
Incidence was relatively more in males. M:F ratio in this series was 
1.36:1. Incidence was nearly equal in rectal carcinoma with slight male 
preponderance in other site carcinomas 4. 
AGE INCIDENCE 
 Range Male Female Total Percentage 
21 – 30 1 1 2 2.56
31 – 40 7 7 14 17.94
41 – 50 6 6 12 15.38
51 – 60 17 14 31 39.74
61 – 70 10 5 15 19.23
> 71 4 0 4 5.12
Total 45 33 78 100
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Site: 
Carcinoma rectum accounted for majority of cases. In 78 patients, 
33 were carcinoma of rectum (42.30 %). The distribution of tumour in the 
other sites in the decreasing order of frequency were as follows., Small 
intestine 4, Colon 27, Rectum including Rectosigmoid junction 33, anal 
canal 14, each. 
48 out of 78 were left sided lesions. 
Mode of Presentation: 
 Majority of the patients though had symptoms for sometime, tend 
to ignore them and presented at late stages. 
17 of the cases in this series presented as acute emergencies 
(21.79%). 12 of them presented with obstructive features. Out of which 3 
were acute on chronic bowel obstruction. 5 patients presented with 
features of bowel perforation with peritonitis 50. 
Majority of the cases of right sided colonic tumours had symptoms 
of altered bowel habits, increasing constipation, bleeding per rectum, 
being the major complaint. Some patients presented with spurious 
diarrhea. Majority of bleeding per rectum were seen in rectum and 
sigmoid lesions .Pain was relatively late symptom. Abdominal lump was 
presented in 5 cases of rectosigmoid growth. 
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SITE INCIDENCE 
Site Male Female Total Percentage 
Right Sided Tumour 9 7 16 20.51 
Left Sided Tumour 37 11 48 61.53 
Anal Canal 8 6 14 17.94 
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SITE INCIDENCE 
 
Site Male Female Total Percentage 
Jejunum & ileum 3 1 4 5.12 
Caecum 2 1 3 3.84 
Ascending Colon 2 2 4 5.12 
Hepatic Flexure 1 1 2 2.56 
Transverse Colon 1 2 3 3.84 
Splenic Flexure 1 2 3 3.84 
Descending Colon 2 3 5 6.41 
Sigmoid Colon 5 2 7 8.97 
Rectosigmoid Junction 9 6 15 19.23 
Rectum 11 7 18 23.07 
Anal Canal 8 6 14 17.94 
Total 45 33 78 100 
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LOWER GI MALIGNANCIES 
SIGN AND SYMPTOMS IN THE SERIES 
 
No. of Cases 
Jejunum
& Ileum 
A. 
Colon
D. 
Colon
T. 
Colon
Sigmoid 
Colon 
Rectum/
Anal 
Canal 
No. of Cases 4 9 8 3 7 47 
Signs / Symptoms       
Pain 2 8 11 3 4 10 
Altered Bowel habits 1 4 8 1 3 12 
Bleeding per rectum - 5 4 - - 18 
Mucus per rectum - - 10 - 2 16 
Tenesmus - - 8 2 3 12 
Lump Abdomen - - - - 3 2 
Hepatomegaly - 4 - - 3 3 
Weight Loss 2 10 20 3 2 18 
Lassitude 1 10 20 4 4 18 
Anemia 1 10 18 2 3 16 
Acute Obstruction 1 - 3 - 2 6 
Peritonitis - - 1 1 1 2 
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Rectal growth was palpated in most cases of carcinoma rectum on 
per rectal examination.  
Transverse colon growth presented with pain abdomen with typical 
history of diarrhoea alternating with constipation. Anemia, anorexia and 
progressive loss of weight was present in majority of cases at all sites. 
12 patients presented with symptoms of metastasis / disseminated 
disease. 3 presented with skeletal metastases mainly in lumbo dorsal 
spine ., out of which one presented with paraplegia. 10 cases presented 
with hepatomegaly, one patient presented with cough, haemoptysis, with 
multiple lung metastases. 
Diagnosis: 
In this series, diagnosing cases of carcinoma of rectum & anal 
canal was not a problem due to late presentation in most of the cases. One 
case of left colon growth perforation was missed due to extensive 
peritonitis with adhesion treated with conservative management. Right 
sided growth tend to present as mass and left sided growth with features 
of mass or obstruction & most of rectal growths were palpated except for 
a  few. Proctoscopic examination was done followed by tests for fecal 
occult blood. USG Abdomen & CT Abdomen was done for all cases & 
initial phase of the disease was studied. Colonoscopy was done for all 
cases, except emergency cases & biopsies taken from the lesions under 
vision or from suspected areas. Contrast studies with Barium ,i.e., Barium 
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meal or Barium enema was done. CEA levels were done for 3 cases., 
levels were raised in all three cases ., average 39 ng / ml .  
 
Pathology and Stage: 
Most of the rectosigmoid and left sided growths were either 
annular and stenosing or ulcerative with infiltration type. Almost all cases 
of carcinoma rectum were of ulcerative type. 3 sigmoid growth showed 
infiltration into surrounding viscera. 2 cases of carcinoma rectum 
presented with posterior vaginal wall infiltration. One patient presented 
with B/L hydronephrosis due to ureteric compression. 
 
HISTOPATHOLOGY: 
Sl.No. Types of CA No. of Cases 
1. Adeno Carcinoma           64 
2. Squamous Carcinoma ( Anal Canal )           12 
3. Malignant Melanoma ( Anal Canal )            2 
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STAGING – COLON & RECTUM 
 
Stage Male Female Total Percentage 
A 0 1 1 1.67 
B 8 7 15 25 
C 10 13 23 38.33 
D 14 7 21 35 
Total 32 28 60 100 
 
 
 
STAGE DISTRIBUTION
2%
25%
38%
35%
STAGE A STAGE B STAGE C STAGE D
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Majority of right sided growths were polypoidal or cauliflower like 
growths. 1 hepatic flexure growth was found to infiltrate into abdominal 
wall. 1 case of multiple polyposis coli with rectal adenocarcinoma 
infiltrating into bladder was diagnosed 25. 2 cases of synchronous tumour 
found, one was synchronous rectal carcinoma and transverse colon 
growth. While the other was synchronous gastric carcinoma (antrum) and 
colonic carcinoma. 
 
STAGING: ( COLON & RECTUM ) 
 Only 1 case presented in Duke Stage A (1.67%), 15 were in Stage 
B (25%), 23 were Stage C (38.33%), 21 in Stage D (35 %). Out of 12 
disseminated malignancies 10 had multiple liver metastases. While two 
had dorsolumbar spine metastasis. One patient presented with multiple 
lung secondaries. Two presented with peritoneal metastasis in the form of 
nodules. 
Grading: 
Moderately differentiated tumour predominated. 41 out of 78 cases 
belonged to this (52.56 %), 21 cases were well differentiated (26.92%) 
and 14 cases were poorly differentiated (17.94 %) type. 
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Treatment Adopted: 
Surgical resection in the form of either curative or palliative 
resection or palliative bypass / colostomy was attempted on all patients 
except 10 . In these 10 , 4 refused surgery and were treated with CT/RT 
while remaining went against medical advice. 
Emergency Cases: 
17 patients presenting as emergencies were taken up., 5 patients 
had perforation with peritonitis. One case of descending colon, 3 cases 
rectosigmoid junction growth and one carcinoma rectum. 
The first has presented with perforation near the proximal margin 
of growth treated with transverse loop colostomy and underwent elective 
resection and anastomosis. One rectal carcinoma presented with caecal 
perforation treated with ileostomy and elective APR later. 
12 cases presenting with bowel obstruction were taken up for 
emergency surgery 20. Out of 6 rectal growths 3 were inoperable, treated 
with Hartmann procedure with end colostomy. ( Fig.29,30 ). Remaining 
were treated with temporary defunctioning colostomy with elective APR 
later.( Fig.31,32 ). Out of 3 growths in rectosigmoid / sigmoid colon, 2 
were inoperable with extensive local infiltration, treated by transverse 
loop colostomy. While in one resection (palliative) done with Hartmann’s 
procedure. One caecal growth was inoperable which was treated by 
ileotransverse anastamosis.( Fig.16 ) 
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Elective Cases: 
51 patients were treated with elective surgery in whom 25 rectal 
carcinomas underwent curative APR with 3 cases treated with anterior 
resection with colo anal anastamosis 27.( Fig.21,22 ). 4 cases underwent 
Haartmann’s procedure. 3 left colon growth were treated with left 
hemicolectomy (Fig.19,20) and 9 patients underwent right 
hemicolectomy (Fig.17,18)., with 2 extended hemicolectomies for 
transverse colon growth, other included cancer caecum and ascending 
colon. Circular staplers were used for 4 cases and sphincter saving 
surgery was performed. ( Fig.28 ). 
 
 
Sl.No. Surgery Numbers 
1. Elective Cases    51 
2. Emergency Cases    17 
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CURATIVE RESECTION 
 
Right Hemicolectomy 9 
Left Hemicolectomy 3 
Segmental Resection / Anastomosis 7 
Anterior Resection 3 
APR 25 
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 Segmental resections were done in 7 cases which, were for 
jejunoileal growth.,rectosigmoid growth & transverse colon growth.  
ADJUVANT THERAPY: 
          The following Regimen was used: 
 I. CA COLON : 
       Inj.Oxaliplatin 100 mg / m 2 from D 1 to D 3 
       Inj. 5 FU 750 mg from D 1 to D 3 
       Inj. Leucoverin 30 mg from D 1 to D 3 
 The above drugs were given for six cycles.  
II. CA RECTUM: 
 The above drugs were given for two cycles followed by 
radiotherapy and then 2 more cycles of chemotherapy.  
III. CA ANAL CANAL: 
 Inj. Mitomycin C  12 mg on D1   
 Inj. 5 FU 750 mg on D1 to D4. With concurrent RT (6000 cGy @ 
200 cGy / day ). 
 48 cases received adjuvant chemotherapy. 8 people refused further 
adjuvant therapy. Radiotherapy was given preoperatively to one patient 
and later underwent Haartmann’s procedure for (carcinoma rectum) 
obstruction. 
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Complications: 
 Significant post operative complications included anastamotic leak, 
faecal fistulae occurred in  7 patients. Surgical site infection occurred in 9 
patients which were treated accordingly. General complications like post 
operative respiratory infection, uraemia, electrolyte imbalance were 
found in 12 patients. Most of them belonged to older age group with 
associated diabetes mellitus and poor general status. One case of stapler 
anastomosis had leak which needed revision.  
Follow up: 
 Follow up was average with most patients failing to turn up after           
3 – 6 cycles of chemotherapy, 10 patients attended the clinic for a long 
time in the follow up period in this study on an average of 20 months and 
1 patient was followed up for 28 months which was the longest. 8 patients 
developed multiple hepatic metastases during follow up. While 3 patients 
had local recurrence, 18 patients had regular follow up with repeat USG 
and basic blood investigations being normal. 
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CONCLUSION 
 
 Most patients were non vegetarians taking a high fat diet. But no 
definite evidence of diet as a risk factor could be identified. 
 Commonest age group of Lower GI Malignancies was on the 6th 
decade. 
 Incidence was higher in males, M : F was 1.36 : 1 
 Carcinoma Rectum was the most commonest site of large bowel 
(42.30%) in the series. 
 17 cases presented with acute emergency in the form of bowel 
obstruction or perforation.( 21.79 % ) 
 Use of Staplers have enabled Sphincter saving surgeries to be done 
& avoids a Permanent Colostomy.  
 To conclude, any patient above 40 years of age, when complaints 
of altered bowel habits or bleeding per rectum, every effort should 
be made thoroughly to investigate him to find out if he harbors 
malignancy of lower GI tract.  
 
 
 
CASE STUDY PROFORMA 
 
Name  :     Age / Sex  : 
IP No. :      DOA   : 
 
Presenting Complaints  
    : 
1. Bleeding per rectum   
2. Abdominal Pain   
3. Tenesmus   
4. Early morning spurious diarrhoea   
5. Constipation   
6. Altered bowel habits   
7. Features of intestinal obstruction   
8. Loss of weight   
9. Loss of appetite   
10. Hemetemesis, Malena   
11. Mass descending per rectum   
12. Back pain   
13. Urinary symptoms   
14. Features of Carcinoid syndrome (Flushing, diarrhoea, 
cyanosis) 
  
 
Previous History of any surgeries for  : ………………………. 
General Condition of the patient : ………………………. 
P.R.     : 
B.P.     : 
Blood Grouping & Typing :  
Clinical Findings   :  
Per Rectal Examination  : 
Growth Position   : 
 
Investigations   : 
1. Urine Albumin :  2. Blood  Sugar : 
Sugar  :     Urea  : 
Deposits :        Serum  Creatinine : 
Complete Hemogram :   Hb% : 
       TC    :  DC         : 
LFT :       ESR   :  Platelets : 
Chest X- RAY :                                         ECG : 
X – RAY Abdomen :                                                                
Motion for Occult blood : 
 Barium Contrast Studies :  Barium Enema  
Barium Meal 
CT Abdomen :    CECT :  
Colonoscopy :  
HPE Grading  : 
 
INTERVENTION : 
Surgical    
Excision 
OPERABLE 
Resection and anastamosis : 
Anterior Resection   : 
Abdomino Perineal Resection : 
INOPERABLE : 
PREOPERATIVE FINDINGS 
Local    : 
Lymph Nodes  : 
Peritoneal Implants :  
Liver Secondaries  : 
 
POST OP FOLLOW UP :  
 
Adjuvant Therapy  :  
 
 
QUESTIONNAIRE 
                                                 (  Model ) 
Name  : Mr.Venkatasamy  
Age / Sex : 72 / M  OP / IP No. : 10011 
Address : P.N. Palayam, Coimbatore. 
 
1. Do you have abdominal pain? Yes / No 
2. Where did the pain first start? Lower Abdomen 
3. Character of pain. Pricking □    Dull Aching 3    Colicky □ 
4. Relation with food. Yes / No 
5. Relation to defecation. Yes / No 
6. Radiation of pain. Yes / No 
7. Do you have any night pain? Yes / No 
8. 
Do you have painful incomplete defecation association 
with bleeding? 
Yes / No 
9. Do you have bleeding per rectum? Yes / No 
10. Amount of bleeding: 
Mild 
Moderate 
Severe 
- 
3 
- 
11. Is the bleeding associated with pain? Yes / No 
12. Do you have constipation on and off? Yes / No 
13. Do you have any change in bowel habits recently? Yes / No 
14. Do you have early morning spurious diarrhea? Yes / No 
15. Do you have fecal incontinence? Yes / No 
16. 
Do you have passage of mucus and blood while 
attempting at defecation? 
Yes / No 
17. 
Do you have a feeling of any mass descending per 
rectum? 
Yes / No 
18. Do you have perianal pruritus? Yes / No 
19. Do you have loss of weight? Yes / No 
20. Do you have loss of appetite? Yes / No 
21. Do you have abdominal distension? Yes / No 
22. Do you smoke? Yes / No 
23. Are you an alcoholic? Yes / No 
24. Do you take mixed diet? Yes / No 
25. Do you take any drug for a prolonged period? Yes / No 
26. Have you undergone any surgery before? Yes / No 
27. 
Is any other family member suffers / suffered from 
similar complaints? 
Yes / No 
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MASTER CHART 
Sl.No. Name Age  Sex IP. No Diagnosis Type of Growth HPE  
Type of 
Resection 
Emergency / 
Elective CT / RT 
1. Mangalam 70 F 23824 CA Rectum ULP PDA APR ELE - 
2. Nagalakshmi 50 F 42247 Splenic Flexure Growth PAP WDA SRA ELE ADJ 
3. Ushakumari 61 F 58220 CA Anal Canal FUG MM - - CRT 
4. Palaniappan 70 M 31042 CA Rectum INF PDA APR ELE ADJ 
5. Madheswaran 55 M 33710 CA Rectum PAP WDA APR ELE ADJ 
6. Chinnasamy 70 M 33936 CA Ascending Colon ULP WDA RHC ELE - 
7. Selvarani 56 F 36812 CA Anal Canal ULP PDS - - CRT 
8. Chinthamani 50 M 38416 CA Rectum PAP WDA APR ELE - 
9. Saraswathy 50 F 19142 CA Rectum PAP WDA APR ELE - 
10. Sivakumar 45 M 56752 CA Rectum ULC WDA APR ELE ADJ 
11. Bathrasammi 70 M 30099 CA Rectum PAP WDA HP EME ADJ 
12. Kambaiyah 70 M 32917 CA Rectum PAP WDA HP EME ADJ 
13. Kalidass 56 M 34397 CA Ceacum ULP WDA RHC ELE ADJ 
14. Natarajan 65 M 41368 CA Rectum INF WDA APR ELE ADJ 
15. Balagurusamy 46 M 42600 CA Hepatic Flexure ULC WDA RHC ELE ADJ 
16. Palaniammal 57 F 45225 CA Anal Canal ULP PDS - - CRT 
17. Karpagam 45 F 46194 CA Rectum PAP MDA APR ELE ADJ 
18. Kalpana 23 F 40392 CA Rectum PAP MDA APR ELE ADJ 
19. Subbathal 60 F 40464 CA Hepatic Flexure ULC MDA RHC ELE ADJ 
20. Dhanalakshmi 38 F 56443 CA Rectum ULC WDA APR ELE ADJ 
21. Rathinam 63 F 22802 CA Ascending Colon ULP WDA RHC ELE ADJ 
22. Saraswathy 48 F 32763 CA Ascending Colon TUB MDA RHC ELE ADJ 
23. Noorjahan 65 F 50971 CA Anal Canal ULP PDS - - CRT 
24. Natchi Muthu 60 M 51477 CA Rectum INF WDA APR ELE ADJ 
25. Iqbal 46 M 309506 CA Ceacum ULP WDA RHC ELE ADJ 
26. Lakshmi 55 F 30672 CA Anal Canal FUG PDS - - CRT 
27. Thangathai 65 F 481705 CA Ceacum PRL MDA - EME ADJ 
 Sl.No. Name Age  Sex IP. No Diagnosis Type of Growth HPE  
Type of 
Resection 
Emergency / 
Elective CT / RT 
28. Rathinasamy 39 M 69436 CA Rectum PAP WDA APR ELE ADJ 
29. Marimuthu 25 M 65308 Growth Ileum PRL WDA SRA ELE ADJ 
30. Chellaiah 62 M 63090 Splenic Flexure Growth PRL WDA LHC ELE ADJ 
31. Rajam 46 F 60531 Splenic Flexure Growth PRL WDA SRA EME ADJ 
32. Vellaisamy 45 M 7508 CA Rectum PAP WDA APR ELE ADJ 
33. Angal 48 F 43159 CA Rectum PAP MDA APR ELE ADJ 
34. Karpagam 55 F 34990 CA Rectum PAP MDA APR ELE ADJ 
35. Saraswathy 40 F 60689 CA Descending Colon ANN MDA SRA ELE ADJ 
36. Arumugam 60 M 51023 CA Rectum ULC MDA HP EME ADJ 
37. Mary 57 F 440124 CA Trans. Colon ULP MDA RHC ELE ADJ 
38. Solai 57 M 45530 CA Rectum PAP MDA APR ELE ADJ 
39. Thangam 56 F 25877 CA Anal Canal FUG PDS - - CRT 
40. Damayanthi 60 F 25823 CA Rectum PAP MDA APR ELE ADJ 
41. Muthu 62 M 7488 CA Descending Colon ANN MDA SRA ELE ADJ 
42. Pushparaj 49 M 187 CA Rectum PAP MDA HP ELE ADJ 
43. Kondathal 55 F 23065 Growth Jejunum PRL MDA SRA EME - 
44. Kalidas 56 M 34397 Growth Ileum ULP MDA SRA EME - 
45. Ramasamy 60 M 20228 CA Anal Canal ULP PDS - - CRT 
46. Patrasamy 70 M 16221 CA Anal Canal FUG MM - - CRT 
47. Rajendran 59 M 53192 CA Anal Canal ULP PDS - - CRT 
48. Marudhachalam 54 M 46841 CA Descending Colon ANN MDA SRA EME - 
49. Sandammal 38 F 73263 CA Rectum PAP MDA APR ELE ADJ 
50. Thandapani 51 M 55094 CA Anal Canal ULP PDS - - CRT 
51. Paramasivam 60 M 59117 CA Anal Canal ULP PDS - - CRT 
52. Karuppathal 37 F 36696 CA Rectum PAP MDA APR ELE ADJ 
53. Parvathiammal 60 F 7626 CA Rectum ULP MDA HP ELE ADJ 
54. Velu 61 M 41678 Growth Ileum PAP MDA SRA EME - 
 
 Sl.No. Name Age  Sex IP. No Diagnosis Type of Growth HPE  
Type of 
Resection 
Emergency / 
Elective CT / RT 
55. Shanmugam 59 M 1527 CA Rectum PAP MDA APR EME - 
56. Venkatasamy 72 M 10011 CA Rectum INF MDA APR ELE ADJ 
57. Palanisamy 55 M 16297 CA Rectum PAP MDA APR ELE ADJ 
58. Chellappan 70 M 23100 CA Rectum ULP MDA APR ELE ADJ 
59. Alexander 35 M 36566 CA Rectum PAP MDA HP ELE ADJ 
60. Mohammed Sarva 58 M 40487 CA Anal Canal ULP PDS - - CRT 
61. Velusamy 75 M 23324 CA Rectum PAP MDA APR ELE ADJ 
62. Malliga 36 F 49997 CA Rectum PAP MDA APR ELE ADJ 
63. Mangalam 38 F 20218 CA Rectum ULC MDA APR ELE ADJ 
64. Manickammal 57 F 26083 CA Trans. Colon ULP MDA SRA EME - 
65. Vellaiammal 55 F 21346 CA Descending Colon ULP MDA LHC ELE ADJ 
66. Nagammal 60 F 21400 CA Descending Colon ANN MDA LHC ELE ADJ 
67. Subramani 57 M 22154 CA Anal Canal ULP PDS - - CRT 
68. Kandasamy 55 M 25413 CA Sigmoid Colon ANN MDA SRA EME - 
69. Alagiri 72 M 60400 CA Ascending Colon ULP MDA RHC ELE ADJ 
70. Kittammal 39 F 53010 Ca Sigmoid Colon TUB MDA SRA EME - 
71. Chinnasamy 78 M 15397 CA Anal Canal ULP PDS - - CRT 
72. Paramasivam 39 M 20124 CA Rectum PRL MDA AR ELE ADJ 
73. Kanagaraj 38 M 15197 Ca Sigmoid Colon ANN MDA HP ELE NDJ 
74. Thangadurai  40 M 60419 Ca Sigmoid Colon ANN MDA SRA ELE - 
75. Lichmon 58 M 21606 Ca Sigmoid Colon TUB MDA SRA ELE - 
76. Lakshmanan 40 M 26308 Ca Sigmoid Colon ANN MDA AR ELE ADJ 
77. Manickavel 40 M 40542 CA Trans. Colon PRL MDA SRA ELE - 
78. Palaniammal 58 F 48445 Ca Sigmoid Colon ANN WDA AR ELE ADJ 
ABBREVIATIONS :          
ULC - Ulcerative; ULP - Ulcero proliferative; PRL - Proliferative; TUB - Tubular; ANN - Annular; PAP - Papliferous; INF - Infiltrative; FUG - Fungating; PDA - Poorly 
differentiated Adeno CA; WDA - Well differentiated Adeno CA; MDA - Moderately differentiated Adeno CA; PDS - Poorly differentiated Sq. Cell CA; MM - Malignant 
Melanoma; APR - Abdomino perineal resection of rectum; AR - Anterior Resection; RHC - Right Hemicolectomy; LHC - Left Hemicolectomy; SRA - Segmental Resection and 
Anastomosis; HP - Haatmann's Procedure; ELE - Elective; EME - Emergency; ADJ - Adjuvant; CT/RT ; NDJ - Neo Adjuvant CT ; CRT - Chemoradiation;  
 
